Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 696,929 shares at $36.31 ($6.7M) on 2021-09-29, disclosed to the SEC on 2021-09-30.
Open-market sale of $6.7M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.75 | 40,000 | $1.5M | 21.8% |
| 2 | $0.00 | 511,727 | $0 | 0.0% |
| 3 | $36.31 | 22,173 | $805K | 11.9% |
| 4 | $36.31 | 34,604 | $1.3M | 18.6% |
| 5 | $36.31 | 22,173 | $805K | 11.9% |
| 6 | $36.31 | 34,604 |
| $1.3M |
| 18.6% |
| 7 | $36.50 | 24,648 | $900K | 13.3% |
| 8 | $36.67 | 7,000 | $257K | 3.8% |
| Total | $9.68 avg | 696,929 | $6.7M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |